Drug recall
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals…
FDA recall event 92073 · Class III · SCA Pharmaceuticals
Key facts
| Event ID | 92073 |
|---|---|
| Recall numbers | D-0555-2023 |
| Recalling firm | SCA Pharmaceuticals |
| Product type | Drugs |
| Products | Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Subpotent Drug: Out of specification results for low potency was obtained. |
| Initiation date | Apr 10, 2023 |
| Report date | May 3, 2023 |
| Termination date | Sep 20, 2023 |
| City | Windsor |
| State | CT |
| Country | United States |
| FEI number | 3013736415 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: